{{Rsnum
|rsid=13147758
|Chromosome=4
|position=144539078
|Orientation=plus
|GMAF=0.2952
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.9 | 45.1 | 15.9
| HCB | 47.4 | 43.8 | 8.8
| JPT | 48.7 | 38.9 | 12.4
| YRI | 95.9 | 4.1 | 0.0
| ASW | 82.5 | 15.8 | 1.8
| CHB | 47.4 | 43.8 | 8.8
| CHD | 46.8 | 45.0 | 8.3
| GIH | 30.7 | 48.5 | 20.8
| LWK | 95.5 | 4.5 | 0.0
| MEX | 41.4 | 51.7 | 6.9
| MKK | 73.7 | 23.1 | 3.2
| TSI | 37.3 | 50.0 | 12.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19300500
|Trait=Pulmonary function measures
|Title=A Genome-Wide Association Study of Pulmonary Function Measures in the Framingham Heart Study
|RiskAllele=G
|Pval=8E-11
|OR=0.10
|ORtxt=[NR] % increase in FEV1/FVC ratio
|OA=1
}}

{{PharmGKB
|RSID=rs13147758
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19300500; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: A Genome-Wide Association Study of Pulmonary Function Measures in the Framingham Heart Study. (Initial Sample Size: 7,691 individuals; Replication Sample Size: 835 individuals); (Region: 4q31.22; Reported Gene(s): HHIP; Risk Allele: rs13147758-G); (p-value= 0.00000000008).This variant is associated with Pulmonary function measures.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164739918
}}

{{PMID Auto
|PMID=20010834
|Title=Genome-wide association study identifies five loci associated with lung function.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs13147758
|overall_frequency_n=33
|overall_frequency_d=128
|overall_frequency=0.257812
|n_genomes=19
|n_genomes_annotated=0
|n_haplomes=24
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}